Piperacillin And Tazobactam
NDC Package 0206-0112-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Piperacillin And Tazobactam is a . Marketed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., this product is identified by NDC 0206-0112 and is authorized under FDA application NDA050684.

Identification & Billing

NDC Package Code
0206-0112-01
Package Description
1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE
Product Code
0206-0112
11-Digit Billing Format
00206011201

Clinical Specifications

Proprietary Name
Piperacillin And Tazobactam Pharmacy Bulk Package
Dosage Form
-

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
FDA Application #
NDA050684
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-01-1993
End Marketing Date
02-29-2016
Listing Expiration
02-29-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0206-0112-01 identifies a specific commercial package of 1 vial, pharmacy bulk package in 1 carton / 180 ml in 1 vial, pharmacy bulk package of Piperacillin And Tazobactam Pharmacy Bulk Package, labeled by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. on November 01, 1993. The current certification is valid through February 29, 2016.

How is this Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00206011201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0206-0112-01
11-Digit CMS (5-4-2)
00206-0112-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.